Cumbrians take part in Pfizer/BioNtech vaccine study
Cumbrian participants have taken part in a study investigating the effectiveness of the Pfizer/BioNTech COVID-19 vaccine.
Public Health England published the first independent analysis of the jab in the UK on Monday which shows it provides high levels of protection against infection and symptomatic disease from the first dose.
The NIHR (National Institute for Health Researrch)-supported SARS-CoV-2 Immunity & REinfection EvaluatioN (SIREN) study aims to find out if prior SARS-CoV-2 infection confers future immunity to reinfection by studying healthcare workersâ immune response to the virus causing COVID-19.
Healthcare workers are one of the earliest groups to be offered the vaccine, therefore this study is likely to provide one of the earliest estimates of vaccine effectiveness against infection.